期刊
CELL STEM CELL
卷 22, 期 6, 页码 810-823出版社
CELL PRESS
DOI: 10.1016/j.stem.2018.05.016
关键词
-
资金
- NIH [U01EB025136, DK105831]
- JDRF Encapsulation Consortium [3-SRA-2015-37-Q-R]
Restoration of insulin independence and normoglycemia has been the overarching goal in diabetes research and therapy. While whole-organ and islet transplantation have become gold-standard procedures in achieving glucose control in diabetic patients, the profound lack of suitable donor tissues severely hampers the broad application of these therapies. Here, we describe current efforts aimed at generating a sustainable source of functional human stem cell-derived insulin-producing islet cells for cell transplantation and present state-of-the-art efforts to protect such cells via immune modulation and encapsulation strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据